March 25 (Reuters) - Advanz Pharma Corp Ltd ADVZ.TO :
* ADVANZ PHARMA CORP. LIMITED ANNOUNCES FOURTH QUARTER AND 2019 RESULTS
* ADVANZ PHARMA CORP - Q4 2019 REVENUE OF $122.0 MILLION, COMPARED TO $117.6 MILLION
* ADVANZ PHARMA CORP - RECORDED ADDITIONAL IMPAIRMENT OF $21.0 MILLION DURING Q4, PRIMARILY RELATED TO PHOTOFRIN ASSET
* ADVANZ PHARMA CORP - Q4 NET LOSS OF $24.6 MILLION